戻る Agenda
Enabling Cell and Gene Therapies: Creating an Appropriate Framework
Session Chair(s)
Marie Manley
Partner, Head of EU and UK Life Sciences (UK)
Sidley Austin LLP, United Kingdom
This session will aim to bring together thought leaders from the industry and advisors to discuss the current regulatory framework, areas for improvement and the use of new tools (such as RWE and digital health) to promote ATMP innovation.
Learning Objective : • Reflect upon whether the current European regulatory framework for the development of ATMPsi s fit for purpose • Discuss novel tools (real world evidence, digital tools) for enabling the development of ATMPs and pricing and reimbursement
Speaker(s)
Panelist
Meindert Boysen, MPharm, MSc
NICE Centre for Health Technology Evaluation (CHTE), United Kingdom
Programme Director Technology Appraisals, PASLU and HST
Panelist
Arianna Greco, JD
Alnylam Pharmaceuticals, Switzerland
SVP Head International Legal
Panelist
Simone Boselli, MA
EURORDIS, Belgium
Public Affairs Director